Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 member and observer countries with diverse trial support services
and contribute to 'infrastructure development' projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

The final CORBEL meeting will take place on 2 March 2020 in Florence, Italy. The consortium will present their solutions for harmonising user access to the European life science research infrastructures (RIs), comprising topics such as access, data or quality management, training, ELSI and innovation support. Presentations by scientists from the biological and medical user communities will illustrate how concerted access to multiple RIs advanced their projects, thus demonstrating the benefit of CORBEL for European life science research.

The one-day meeting will be open to European scientists from the biological and medical field, potential users of the CORBEL common services as well as other stakeholders generally interested in CORBEL and the European life science RIs.

For registration information, please click here
 

Date:

The RE(ACT) Congress & IRDiRC Conference 2020 will take place in Berlin, Germany from 11 to 14 March 2020.

This joint event will continue the RE(ACT) Congress series (6th edition) and IRDiRC Conference series (4th edition). It aims to bring together scientific leaders and experts and young scientists from a variety of breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research. Patients and patient organizations, who are committed to research, will also be in attendance to share their experiences and perspectives.

The scientific programme has been inspired by IRDiRC principles and achievements and by the IRDiRC activities foreseen in 2020. It encompasses topics like diagnosis and artificial intelligence, molecular etiology, innovative clinical trials, patient engagement, and drugs for all. 

The RE(ACT) Congress – International Congress of Research on Rare and Orphan Diseases – was initiated in 2012 by the BLACKSWAN Foundation to create a forum for and promote scientific cooperation and research on rare and orphan diseases. IRDiRC – launched in April 2011 at the initiative of the European Commission and the US National Institutes of Health – fosters international collaboration on rare disease research by bringing together researchers, funders and patient advocacy organizations that work collaboratively within a multinational consortium.

The joint edition of the 6th edition of the RE(ACT) Congress and the 4th IRDiRC Conference to be held in Berlin, Germany, from 11-14 March 2020 is being organised in collaboration with the European Joint Program Rare Diseases (EJP RD) and in partnership with Eurordis (European alliance of patient organizations) and RDI – Rare Diseases International (global alliance of people living with a rare disease).

To register, click here

Visit the event website

Date:

The RI-VIS Africa-Europe Symposium will be held on Monday, March 23rd and Tuesday, March 24th, 2020 in Cape Town, South Africa.

The two-day symposium will bring together staff from the European infrastructures and South African and other African research infrastructures and institutions who might be interested in collaborating. Representatives from relevant funding agencies as well as policy makers are invited to join.

The aim is to foster collaboration and initiate networks in a sustainable way so that all stakeholders benefit.

For more information and to register, click here